0001209191-19-059404.txt : 20191205 0001209191-19-059404.hdr.sgml : 20191205 20191205213520 ACCESSION NUMBER: 0001209191-19-059404 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191203 FILED AS OF DATE: 20191205 DATE AS OF CHANGE: 20191205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kroll Werner CENTRAL INDEX KEY: 0001609320 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 191271621 MAIL ADDRESS: STREET 1: 12544 HIGH BLUFF DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 MAIL ADDRESS: STREET 1: 9975 SUMMERS RIDGE ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-12-03 0 0000353569 QUIDEL CORP /DE/ QDEL 0001609320 Kroll Werner 9975 SUMMERS RIDGE ROAD SAN DIEGO CA 92121 0 1 0 0 SVP, R&D Common Stock 2019-12-03 4 S 0 3357 68.0285 D 16769 D Common Stock 2019-12-03 4 M 0 6620 22.85 A 23389 D Common Stock 2019-12-03 4 S 0 6620 68.0105 D 16769 D Common Stock 2019-12-03 4 S 0 12974 68.0189 D 3795 D Non-Qualified Stock Options 22.85 2019-12-03 4 M 0 6620 0.00 D 2024-05-27 Common Stock 6620 0 D The weighted average sale price for these transactions was $68.028508 per share, with a range of $67.95 to $68.10. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The amount of securities beneficially owned following this transaction include an additional 357 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan. The weighted average sale price for these transactions was $68.010509 per share, with a range of $67.95 to $68.12. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. The weighted average sale price for these transactions was $66.018852 per share, with a range of $67.95 to $68.12. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price. 13,242 shares vested on the second anniversary date of the grant date, May 27, 2016. 6,621 shares vested on the third anniversary date of the grant date, May 27, 2017. 6,620 shares vested on the fourth anniversary date of the grant date, May 27, 2018. Robert J. Bujarski, attorney-in-fact for Werner Kroll 2019-12-05